Life Sciences
Top stories summarized by our editors
4/25/2017

For the past 6 years, our publisher Brian Johnson has interviewed the most successful men and women in the medical device industry at our DeviceTalks events. Over time, he's discovered a commonality of traits. For example, former Stryker CEO John Brown hates to lose -- a sentiment many others express. Top executives including former Medtronic CEO Bill Hawkins are adept at finding their way around obstacles. And leaders such as Boston Scientific CEO Michael Mahoney know how to take culture seriously. Discover more at DeviceTalks Minnesota, June 26-27. Read the story.

4/25/2017

The Senate Committee on Health, Education, Labor and Pensions is scheduled to vote Wednesday on the nomination of Scott Gottlieb to serve as FDA commissioner, and the committee is expected to approve the nomination.

Full Story:
The Hill
4/25/2017

Ghana, Kenya and Malawi will offer GlaxoSmithKline's injectable malaria vaccine, Mosquirix, for babies and children in high-risk areas starting in 2018, according to the World Health Organization, which will use the results of the pilot program as a basis for recommending the vaccine. The PATH Malaria Vaccine Initiative and the Bill & Melinda Gates Foundation worked with GSK to develop the vaccine, and the pilot study is being funded by Gavi, the Vaccine Alliance, UNITAID and the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Full Story:
Reuters
4/25/2017

European regulators have given Synaptive Medical CE mark approval for its BrightMatter Plan neurosurgical planning system, which enables automatic generation of 3D images of the brain using diffusion tensor imaging. The technology also has been approved by regulators in Australia.

More Summaries:
Synaptive Medical
4/25/2017

Sanofi's Thymoglobulin has been approved by the FDA as a treatment to be used in conjunction with concomitant immunosuppression for the prevention of acute kidney transplant rejection in patients.

Full Story:
Reuters
More Summaries:
immunosuppression, Thymoglobulin
4/25/2017

The FDA has approved the investigational new drug application filed by AnGes for its clinical trial of F-kappaB decoy oligo DNA as a treatment for discogenic lower back pain.

Full Story:
Reuters
More Summaries:
FDA
4/25/2017

Pooled results from two late-stage trials of Adamas Pharmaceuticals' ADS-5102, or amantadine, showed that the drug produced a statistically significant reduction in "off time" and a significant reduction in dyskinesia associated with levodopa in patients with Parkinson's disease.

4/25/2017

Zydus Cadila has received FDA approval to market its anti-hypertensive Olmesartan Medoxomil tablets in the US. The drugs will be manufactured at the company's facility at Pharma SEZ in Ahmedabad, India.

More Summaries:
Zydus Cadila, Ahmedabad
4/25/2017

A nationwide recall has been issued by WFSP Foods for more than 21 tons of Chef's Line All Natural Fire Grilled Chicken Breast and Fully Cooked Flame Grilled Chicken Breast Fillets because of multiple consumer claims that the products were undercooked, prompting concern about possible contamination with bacterial pathogens. The recalled items have the establishment number P-45411 and were distributed to restaurant, hotel and institution locations nationwide from an Illinois distribution center.

Full Story:
Food Safety News
More Summaries:
WFSP Foods
4/25/2017

The S8, the new version of the StealthStation neurosurgery system, has been launched by Medtronic for tracking the location of tools and processing imaging data. The model provides easy guidance as it comes with the ability to merge data from Medtronic's O-arm X-ray-based imaging system, intrasurgical MRIs, CT scanners and fluoroscopes.

Full Story:
MedGadget
More Summaries:
Medtronic